Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-15EMA Authorised: Paxneury (guanfacine hydrochloride) — Neuraxpharm Pharmaceuticals S.L.
The EMA has authorised Paxneury (guanfacine hydrochloride) for attention deficit disorder with hyperactivity, with Neuraxpharm Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Update: Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) [Phase 3]
Open-label Phase 3 study assessing long-term safety and efficacy of viloxazine extended-release for ADHD (SPN-812).
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. [Phase 3]
Phase 3 efficacy and safety results for CTx-1301 in adults with ADHD have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Improving the Outcomes of Adolescents With ADHD Via a Pre-visit Question Prompt List/Video Intervention [NA]
Results from a completed clinical trial evaluating a pre-visit question prompt list/video intervention to improve outcomes for adolescents w…
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Mobile Behavioral Parent Training for Childhood ADHD: A Micro-randomized Trial [NA]
A micro-randomized trial evaluating mobile behavioral parent training for childhood ADHD has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Community-Based Care for Minority Adolescents With ADHD: Improving Fidelity With Machine Learning-Assisted Supervision and Fidelity Feedback. [NA]
This completed clinical trial evaluates a community-based care model for minority adolescents with ADHD, using machine-learning-assisted sup…
-
CLINICAL_TRIALS withdrawal · 2026-04-24Clinical Trial Update: Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges [Phase 2, Phase 3]
The Phase 2/Phase 3 trial evaluating a digital strategy-based educational skills group for secondary students with ADHD has been withdrawn.
-
FDA approval · 2026-04-23FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for the four mixed amphetamine salt components: dextroamphetamine saccharat…
-
FDA label_change · 2026-04-23FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse to update its labeling (indications/usage) following regulatory action.
-
FDA approval · 2026-04-23FDA Approved: MYDAYIS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for MYDAYIS, a mixed amphetamine salts product, submitted by Takeda Pharmaceuticals America, Inc…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease [Phase 1]
This is a Phase 1 clinical trial evaluating methylphenidate for attention and executive function deficits in children with sickle cell disea…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Feasibility Trial of a Guided Internet-delivered Intervention for Adolescents With ADHD [NA]
Feasibility trial of a guided internet-delivered intervention for adolescents with ADHD; sponsored by Haukeland University Hospital; the stu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health [NA]
A University of Pennsylvania clinical trial is evaluating a measurement-feedback app to improve data quality, supervision, and outcomes in p…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients
ClinicalTrials.gov entry for the MOCHA study describes an embedded inpatient mental health program for high-risk perinatal patients. The tri…
-
FDA approval · 2026-04-21FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Tailored Yoga Therapy for Attention-deficit Hyperactivity Disorder [NA]
King's College London is conducting a study to evaluate tailored yoga therapy for ADHD symptoms; the trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Efficacy of the Apollo System for Children With ADHD [NA]
Clinical trial update on the efficacy of the Apollo System for children with Attention-Deficit/Hyperactivity Disorder; the study is currentl…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: ADOLESCENTS IMAGING USING fMRI: Feasibility Study [NA]
A feasibility imaging study in adolescents to assess fMRI protocols in those with borderline personality disorder or ADHD, with healthy cont…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants [Phase 4]
A Phase 4 clinical trial is examining predictors of improvement in irritability and aggression among children with ADHD treated with CNS sti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Attention Deficit Hyperactivity Disorder [NA]
A clinical trial at Nantes University Hospital focusing on Attention deficit hyperactivity disorder and related behavioral conditions is cur…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery [NA]
Clinical trial update describing a study to characterize social cognition profiles in children and adolescents with neurodevelopmental disor…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: HOPS Study: A Conceptual Replication [NA]
The HOPS Study, a conceptual replication sponsored by Children's Hospital of Philadelphia, is currently active but not recruiting. It focuse…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
A clinical trial update indicating ongoing recruitment to validate the Five Digits Test, a neuropsychological measure of inhibition, in indi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder [Phase 1]
A Phase 1 study to evaluate the tolerability of BI 3031185 in adults with borderline personality disorder or attention-deficit/hyperactivity…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) [Phase 3]
This document reports a completed Phase 3 trial evaluating the efficacy and safety of centanafadine in children with Attention-Deficit/Hyper…